Evidence map›Paper›PMID 29903763›Full record

ArticleHaematologica2018

A novel type of

Nicolas Duployez, Lydia Chebrek, Nathalie Helevaut, Elise Fournier, Maxime Bemba, Aurélie Caillault, Sandrine Geffroy, Claude Preudhomme

Open access · goldAbstract readCase ReportsLetter
In one paragraph

Article in Haematologica, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Targeting and Monitoring Acute Myeloid Leukaemia with Nucleophosmin-1 (International journal of molecular sciences · 2023
    Review
  5. Article
  6. Mutant NPM1-Regulated FTO-Mediated mFrontiers in oncology · 2022
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Nicolas DuployezCHU Lille, Laboratory of Hematology nicolas.duployez@chru-lille.fr.
Lydia ChebrekCHU Lille, Laboratory of Hematology.
Nathalie HelevautCHU Lille, Laboratory of Hematology.
Elise FournierUniv. Lille, INSERM, UMR-S 1172.
Maxime BembaCH Dunkerque, Hematology Department, F-59385, France.
Aurélie CaillaultCHU Lille, Laboratory of Hematology.
Sandrine GeffroyCHU Lille, Laboratory of Hematology.
Claude PreudhommeCHU Lille, Laboratory of Hematology.
Inserm · FRUniversité de Lille · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

MutationAcute DiseaseAgedAmino Acid SequenceBase SequenceDNA Mutational AnalysisFemaleHumansLeukemia, MyeloidNuclear ProteinsNucleophosminRetrospective StudiesSequence Homology, Amino AcidSequence Homology, Nucleic AcidTandem Repeat SequencesNPM1 protein, humanNuclear ProteinsNucleophosmin

Identifiers

PMID29903763
PMCPMC6269301
OpenAlexW2808008303

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.